Rutgers Health – News Release issued September 12, 2024 New study will examine impact of severe weather on vulnerable populations and identify strategies to strengthen resiliency With the frequency … Read More
Learn more about the International Society of Pharmacoepidemiology’s Annual Meeting. The Rutgers Center for Pharmacoepidemiology and Treatment Sciences (PETS) facilitates and performs innovative, multidisciplinary science related to the use and … Read More
In response to the policy changes in data access recently announced by the Centers for Medicare and Medicaid Services (CMS), Rutgers University researchers sent a letter to CMS leadership on April … Read More
About Daniel Lam is a medical student at Rutgers, Robert Wood Johnson Medical School working under the guidance of Dr. Daniel B. Horton. He previously earned a B.S. in Neurobiology, … Read More
About Priyanka Yalamanchili graduated from Rutgers University with a Doctor of Pharmacy (PharmD) degree in 2021 and Master of Science (MS) degree in Epidemiology with a concentration in Pharmacoepidemiology in … Read More
About Tobias Gerhard is a pharmacoepidemiologist and the Founding Director of the Rutgers Center for Pharmacoepidemiology and Treatment Science (PETS). He also serves as Director of the Institute for Health, … Read More
About Chintan Dave, a pharmacoepidemiologist and health economist, joined PETS and Ernest Mario College of Pharmacy in 2019 as an Assistant Professor of Pharmacy. He received his pharmacy degree from … Read More
About Daniel Horton is a pediatric rheumatologist and pharmacoepidemiologist who performs clinical, translational, and health services research. He started at Rutgers in 2016 as an Assistant Professor and Chancellor’s Scholar … Read More
About Mary Beth Ritchey is a part-time Associate Research Professor at PETS where she conducts pharmacoepidemiology research, teaches, and mentors students/fellows in pharmacoepidemiology methodology. Outside of PETS, she is the … Read More
By Patti Verbanas Date March 22, 2022 Media Contact Nicole Swenarton | 732-284-6326 | ns1332@ifh.rutgers.edu Medication for opioid use disorder was lowest among adolescents and adults ages 50 or older, Rutgers … Read More